On a consensus basis, Wall Street sell-side analysts have a mean target price of $48.666 for Imperva, Inc. (NYSE:IMPV). This number is based on the mean estimate from the 12 research firms that recently issued reports on the company.
According to analysts, Imperva, Inc. (NYSE:IMPV) is expected to report earnings per share for the current fiscal quarter of $-0.68. This is the consensus mean estimate based on the individual covering sell-side analysts’ reported numbers. The company last reported earnings for the period ending on 2014-12-31 of $-0.47.
The average broker recommendation is arithmetical average of the individual ratings contributed by sell-side analysts to produce a Consensus Analyst Rating for each stock. On a scale of 1 to 5 where 1 is a Strong Buy and 5 is a Strong Sell, has the stock is ranked 1.62 based on 12 sell-side broker recommendations. Of the 12 analyst estimates, the most bullish sees the stock reaching $58 within the next 12 months while the most bearish analyst sees the stock at $44 within the year.
In looking at the long term growth prospects of the company, sell-side analysts have a consensus mean earnings per share estimate for the current year of $-2.33. The high end estimate for this time frame is $-2.1 with the low being $-2.51. In looking at the next three to five years, the long term earnings per share estimate growth rate for the company is 25%, based on 2 analysts providing projections.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...